Virginia Retirement System’s Vertex Pharmaceuticals VRTX Stock Holding History

Virginia Retirement System’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$317K	Buy	+3,984	New	+$360K	﹤0.01%	848

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virginia Retirement System's VRTX Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2016: 3,984 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #848 among its holdings.

502 funds tracked by Wall St. Rank hold VRTX as of Q1 2016.

Virginia Retirement System held 3,984 shares of Vertex Pharmaceuticals worth $317K as of Q1 2016.
Vertex Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Vertex Pharmaceuticals made up ﹤0.01% of Virginia Retirement System's portfolio in Q1 2016, its #848 holding.
502 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.